疾病通路的编号,疾病名称,通路名称,通路编号,类型,类型ID
hsa05010,Alzheimer disease,Mutation-caused aberrant Abeta to mGluR5-Ca2+ -apoptotic pathway,N01002,Alzheimer disease,nt06460
hsa05010,Alzheimer disease,Mutation-caused aberrant Abeta to mGluR5-Ca2+ -apoptotic pathway,N01002,Pathways of neurodegeneration,nt06466
hsa05010,Alzheimer disease,Mutation-caused aberrant PSEN1 to mGluR5-Ca2+ -apoptotic pathway,N01008,Alzheimer disease,nt06460
hsa05010,Alzheimer disease,Mutation-caused aberrant PSEN1 to mGluR5-Ca2+ -apoptotic pathway,N01008,Pathways of neurodegeneration,nt06466
hsa05010,Alzheimer disease,Mutation-caused aberrant PSEN to mGluR5-Ca2+ -apoptotic pathway,N01007,Alzheimer disease,nt06460
hsa05010,Alzheimer disease,Mutation-caused aberrant PSEN to mGluR5-Ca2+ -apoptotic pathway,N01007,Pathways of neurodegeneration,nt06466
hsa05010,Alzheimer disease,Mutation-caused aberrant Abeta to mAchR-Ca2+ -apoptotic pathway,N01001,Alzheimer disease,nt06460
hsa05010,Alzheimer disease,Mutation-caused aberrant Abeta to mAchR-Ca2+ -apoptotic pathway,N01001,Pathways of neurodegeneration,nt06466
hsa05010,Alzheimer disease,Mutation-caused aberrant Abeta to VGCC-Ca2+ -apoptotic pathway,N01004,Alzheimer disease,nt06460
hsa05010,Alzheimer disease,Mutation-caused aberrant Abeta to VGCC-Ca2+ -apoptotic pathway,N01004,Pathways of neurodegeneration,nt06466
hsa05010,Alzheimer disease,Mutation-caused aberrant Abeta to VGCC-Ca2+ -apoptotic pathway,N01006,Alzheimer disease,nt06460
hsa05010,Alzheimer disease,Mutation-caused aberrant Abeta to VGCC-Ca2+ -apoptotic pathway,N01006,Pathways of neurodegeneration,nt06466
hsa05010,Alzheimer disease,Mutation-caused aberrant Abeta to transport of calcium,N01003,Alzheimer disease,nt06460
hsa05010,Alzheimer disease,Mutation-caused aberrant Abeta to transport of calcium,N01003,Pathways of neurodegeneration,nt06466
hsa05010,Alzheimer disease,Mutation-caused aberrant Abeta to 26S proteasome-mediated protein degradation,N01060,Alzheimer disease,nt06460
hsa05010,Alzheimer disease,Mutation-caused aberrant Abeta to 26S proteasome-mediated protein degradation,N01060,Pathways of neurodegeneration,nt06466
hsa05010,Alzheimer disease,Mutation-caused aberrant PSEN1 to PERK-ATF4 signaling pathway,N01010,Unfolded protein response,nt06534
hsa05010,Alzheimer disease,Mutation-caused aberrant PSEN1 to PERK-ATF4 signaling pathway,N01010,Alzheimer disease,nt06460
hsa05010,Alzheimer disease,Mutation-caused aberrant PSEN1 to PERK-ATF4 signaling pathway,N01010,Pathways of neurodegeneration,nt06466
hsa05010,Alzheimer disease,Mutation-caused aberrant PSEN1 to IRE1a-XBP1 signaling pathway,N01012,Unfolded protein response,nt06534
hsa05010,Alzheimer disease,Mutation-caused aberrant PSEN1 to IRE1a-XBP1 signaling pathway,N01012,Alzheimer disease,nt06460
hsa05010,Alzheimer disease,Mutation-caused aberrant PSEN1 to IRE1a-XBP1 signaling pathway,N01012,Pathways of neurodegeneration,nt06466
hsa05010,Alzheimer disease,Mutation-caused aberrant Abeta to IRE1a-JNK signaling pathway,N01014,Unfolded protein response,nt06534
hsa05010,Alzheimer disease,Mutation-caused aberrant Abeta to IRE1a-JNK signaling pathway,N01014,Alzheimer disease,nt06460
hsa05010,Alzheimer disease,Mutation-caused aberrant Abeta to IRE1a-JNK signaling pathway,N01014,Pathways of neurodegeneration,nt06466
hsa05010,Alzheimer disease,Mutation-caused aberrant PSEN1 to ATF6-mediated transcription,N01016,Unfolded protein response,nt06534
hsa05010,Alzheimer disease,Mutation-caused aberrant PSEN1 to ATF6-mediated transcription,N01016,Alzheimer disease,nt06460
hsa05010,Alzheimer disease,Mutation-caused aberrant PSEN1 to ATF6-mediated transcription,N01016,Pathways of neurodegeneration,nt06466
hsa05010,Alzheimer disease,Mutation-caused aberrant Abeta to crosstalk between extrinsic and intrinsic apoptotic pathways,N01005,Alzheimer disease,nt06460
hsa05010,Alzheimer disease,Mutation-caused aberrant Abeta to crosstalk between extrinsic and intrinsic apoptotic pathways,N01005,Pathways of neurodegeneration,nt06466
hsa05010,Alzheimer disease,Mutation-caused aberrant Abeta to AGE-RAGE signaling pathway,N00996,Alzheimer disease,nt06460
hsa05010,Alzheimer disease,Mutation-caused aberrant Abeta to AGE-RAGE signaling pathway,N00996,Pathways of neurodegeneration,nt06466
hsa05010,Alzheimer disease,Mutation-caused aberrant Abeta to electron transfer in Complex I,N00997,Alzheimer disease,nt06460
hsa05010,Alzheimer disease,Mutation-caused aberrant Abeta to electron transfer in Complex I,N00997,Pathways of neurodegeneration,nt06466
hsa05012,Parkinson disease,Manganese to electron transfer in Complex II,N01402,Alzheimer disease,nt06460
hsa05012,Parkinson disease,Manganese to electron transfer in Complex II,N01402,Parkinson disease,nt06463
hsa05012,Parkinson disease,Manganese to electron transfer in Complex II,N01402,Pathways of neurodegeneration,nt06466
hsa05010,Alzheimer disease,Mutation-caused aberrant Abeta to electron transfer in Complex IV,N00999,Alzheimer disease,nt06460
hsa05010,Alzheimer disease,Mutation-caused aberrant Abeta to electron transfer in Complex IV,N00999,Pathways of neurodegeneration,nt06466
hsa05010,Alzheimer disease,Mutation-caused aberrant PSEN1 to anterograde axonal transport,N01017,Alzheimer disease,nt06460
hsa05010,Alzheimer disease,Mutation-caused aberrant PSEN1 to anterograde axonal transport,N01017,Pathways of neurodegeneration,nt06466
hsa05010,Alzheimer disease,Mutation-caused aberrant Abeta to anterograde axonal transport,N01018,Alzheimer disease,nt06460
hsa05010,Alzheimer disease,Mutation-caused aberrant Abeta to anterograde axonal transport,N01018,Pathways of neurodegeneration,nt06466
hsa05010,Alzheimer disease,Zn to anterograde axonal transport,N01403,Alzheimer disease,nt06460
hsa05010,Alzheimer disease,Zn to anterograde axonal transport,N01403,Pathways of neurodegeneration,nt06466
hsa05010,Alzheimer disease,Iron to anterograde axonal transport,N01414,Alzheimer disease,nt06460
hsa05010,Alzheimer disease,Iron to anterograde axonal transport,N01414,Pathways of neurodegeneration,nt06466
hsa05010,Alzheimer disease,Mercury to NEP-mediated Abeta degradation,N01416,Alzheimer disease,nt06460
hsa05012,Parkinson disease,Mutation-inactivated PRKN to mGluR1 signaling pathway,N01032,Parkinson disease,nt06463
hsa05012,Parkinson disease,Mutation-inactivated PRKN to mGluR1 signaling pathway,N01032,Pathways of neurodegeneration,nt06466
hsa05012,Parkinson disease,Mutation-caused aberrant SNCA to VGCC-Ca2+ -apoptotic pathway,N01031,Parkinson disease,nt06463
hsa05012,Parkinson disease,Mutation-caused aberrant SNCA to VGCC-Ca2+ -apoptotic pathway,N01031,Pathways of neurodegeneration,nt06466
hsa05012,Parkinson disease,Mutation-inactivated PRKN to Parkin-mediated ubiquitination,N01020,Parkinson disease,nt06463
hsa05012,Parkinson disease,Mutation-inactivated PRKN to Parkin-mediated ubiquitination,N01020,Pathways of neurodegeneration,nt06466
hsa05012,Parkinson disease,Mutation-inactivated PRKN to Parkin-mediated ubiquitination,N01022,Parkinson disease,nt06463
hsa05012,Parkinson disease,Mutation-inactivated PRKN to Parkin-mediated ubiquitination,N01022,Pathways of neurodegeneration,nt06466
hsa05012,Parkinson disease,Mutation-inactivated PRKN to Parkin-mediated ubiquitination,N01024,Parkinson disease,nt06463
hsa05012,Parkinson disease,Mutation-inactivated PRKN to Parkin-mediated ubiquitination,N01024,Pathways of neurodegeneration,nt06466
hsa05012,Parkinson disease,Mutation-inactivated PRKN to Parkin-mediated ubiquitination,N01026,Parkinson disease,nt06463
hsa05012,Parkinson disease,Mutation-inactivated PRKN to Parkin-mediated ubiquitination,N01026,Pathways of neurodegeneration,nt06466
hsa05012,Parkinson disease,Mutation-caused aberrant SNCA to 26S proteasome-mediated protein degradation,N01030,Parkinson disease,nt06463
hsa05012,Parkinson disease,Mutation-caused aberrant SNCA to 26S proteasome-mediated protein degradation,N01030,Pathways of neurodegeneration,nt06466
hsa05012,Parkinson disease,Mutation-inactivated UCHL1 to UCHL1-mediated hydrolysis,N01028,Parkinson disease,nt06463
hsa05012,Parkinson disease,Mutation-inactivated UCHL1 to UCHL1-mediated hydrolysis,N01028,Pathways of neurodegeneration,nt06466
hsa05012,Parkinson disease,Mutation-caused aberrant SNCA to PERK-ATF4 signaling pathway,N01035,Unfolded protein response,nt06534
hsa05012,Parkinson disease,Mutation-caused aberrant SNCA to PERK-ATF4 signaling pathway,N01035,Parkinson disease,nt06463
hsa05012,Parkinson disease,Mutation-caused aberrant SNCA to PERK-ATF4 signaling pathway,N01035,Pathways of neurodegeneration,nt06466
hsa05012,Parkinson disease,Mutation-caused aberrant SNCA to IRE1a-XBP1 signaling pathway,N01034,Unfolded protein response,nt06534
hsa05012,Parkinson disease,Mutation-caused aberrant SNCA to IRE1a-XBP1 signaling pathway,N01034,Parkinson disease,nt06463
hsa05012,Parkinson disease,Mutation-caused aberrant SNCA to IRE1a-XBP1 signaling pathway,N01034,Pathways of neurodegeneration,nt06466
hsa05012,Parkinson disease,Mutation-caused aberrant SNCA to ATF6-mediated transcription,N01033,Unfolded protein response,nt06534
hsa05012,Parkinson disease,Mutation-caused aberrant SNCA to ATF6-mediated transcription,N01033,Parkinson disease,nt06463
hsa05012,Parkinson disease,Mutation-caused aberrant SNCA to ATF6-mediated transcription,N01033,Pathways of neurodegeneration,nt06466
hsa05012,Parkinson disease,Mutation-inactivated PINK1 to PINK1-Parkin-mediated MFN2 degradation,N01053,Parkinson disease,nt06463
hsa05012,Parkinson disease,Mutation-inactivated PINK1 to PINK1-Parkin-mediated MFN2 degradation,N01053,Pathways of neurodegeneration,nt06466
hsa05012,Parkinson disease,Mutation-inactivated PRKN to PINK1-Parkin-mediated MFN2 degradation,N01054,Parkinson disease,nt06463
hsa05012,Parkinson disease,Mutation-inactivated PRKN to PINK1-Parkin-mediated MFN2 degradation,N01054,Pathways of neurodegeneration,nt06466
hsa05012,Parkinson disease,Mutation-inactivated DJ1 to intrinsic apoptotic pathway,N01051,Parkinson disease,nt06463
hsa05012,Parkinson disease,Mutation-inactivated DJ1 to intrinsic apoptotic pathway,N01051,Pathways of neurodegeneration,nt06466
hsa05012,Parkinson disease,Mutation-inactivated PINK1 to intrinsic apoptotic pathway,N01050,Parkinson disease,nt06463
hsa05012,Parkinson disease,Mutation-inactivated PINK1 to intrinsic apoptotic pathway,N01050,Pathways of neurodegeneration,nt06466
hsa05012,Parkinson disease,Mutation-inactivated PRKN to intrinsic apoptotic pathway,N01049,Parkinson disease,nt06463
hsa05012,Parkinson disease,Mutation-inactivated PRKN to intrinsic apoptotic pathway,N01049,Pathways of neurodegeneration,nt06466
hsa05012,Parkinson disease,Mutation-inactivated PINK1 to intrinsic apoptotic pathway,N01048,Parkinson disease,nt06463
hsa05012,Parkinson disease,Mutation-inactivated PINK1 to intrinsic apoptotic pathway,N01048,Pathways of neurodegeneration,nt06466
hsa05012,Parkinson disease,Mutation-activated LRRK2 to intrinsic apoptotic pathway,N01047,Parkinson disease,nt06463
hsa05012,Parkinson disease,Mutation-activated LRRK2 to intrinsic apoptotic pathway,N01047,Pathways of neurodegeneration,nt06466
hsa05012,Parkinson disease,Mutation-inactivated DJ1 to FAS-JNK signaling patwhay,N01057,Parkinson disease,nt06463
hsa05012,Parkinson disease,Paraquat to FAS-JNK signaling pathway,N01417,Parkinson disease,nt06463
hsa05012,Parkinson disease,Mutation-caused aberrant SNCA to L-DOPA generation,N01037,Dopamine and serotonin metabolism,nt06028
hsa05012,Parkinson disease,Mutation-caused aberrant SNCA to L-DOPA generation,N01037,Parkinson disease,nt06463
hsa05012,Parkinson disease,Mutation-inactivated PRKN to DOPAL generation,N01039,Dopamine and serotonin metabolism,nt06028
hsa05012,Parkinson disease,Mutation-inactivated PRKN to DOPAL generation,N01039,Parkinson disease,nt06463
hsa05012,Parkinson disease,Mutation-caused aberrant SNCA to transport of dopamine,N01041,Dopamine and serotonin metabolism,nt06028
hsa05012,Parkinson disease,Mutation-caused aberrant SNCA to transport of dopamine,N01041,Parkinson disease,nt06463
hsa05012,Parkinson disease,Mutation-caused aberrant SNCA to electron transfer in Complex I,N01042,Parkinson disease,nt06463
hsa05012,Parkinson disease,Mutation-caused aberrant SNCA to electron transfer in Complex I,N01042,Pathways of neurodegeneration,nt06466
hsa05012,Parkinson disease,Mutation-inactivated PINK1 to electron transfer in Complex I,N01043,Parkinson disease,nt06463
hsa05012,Parkinson disease,Mutation-inactivated PINK1 to electron transfer in Complex I,N01043,Pathways of neurodegeneration,nt06466
hsa05012,Parkinson disease,MPP+ to electron transfer in Complex I,N01044,Parkinson disease,nt06463
hsa05012,Parkinson disease,MPP+ to electron transfer in Complex I,N01044,Pathways of neurodegeneration,nt06466
hsa05012,Parkinson disease,Rotenone to electron transfer in Complex I,N01045,Parkinson disease,nt06463
hsa05012,Parkinson disease,Rotenone to electron transfer in Complex I,N01045,Pathways of neurodegeneration,nt06466
hsa05012,Parkinson disease,Manganese to electron transfer in Complex II,N01402,Alzheimer disease,nt06460
hsa05012,Parkinson disease,Manganese to electron transfer in Complex II,N01402,Parkinson disease,nt06463
hsa05012,Parkinson disease,Manganese to electron transfer in Complex II,N01402,Pathways of neurodegeneration,nt06466
hsa05012,Parkinson disease,Maneb to electron transfer in Complex III,N01046,Parkinson disease,nt06463
hsa05012,Parkinson disease,Maneb to electron transfer in Complex III,N01046,Pathways of neurodegeneration,nt06466
hsa05012,Parkinson disease,Mutation-caused aberrant SNCA to anterograde axonal transport,N01055,Parkinson disease,nt06463
hsa05012,Parkinson disease,Mutation-caused aberrant SNCA to anterograde axonal transport,N01055,Pathways of neurodegeneration,nt06466
hsa05012,Parkinson disease,Mutation-inactivated DJ1 to to p53-mediated transcription,N01058,Parkinson disease,nt06463
hsa05012,Parkinson disease,Mutation-inactivated DJ1 to KEAP1-NRF2 signaling pathway,N01059,Parkinson disease,nt06463
hsa05014,Amyotrophic lateral sclerosis,Mutation-inactivated SIGMAR1 to Ca2+ -apoptotic pathway,N01151,Amyotrophic lateral sclerosis,nt06464
hsa05014,Amyotrophic lateral sclerosis,Mutation-inactivated SIGMAR1 to Ca2+ -apoptotic pathway,N01151,Pathways of neurodegeneration,nt06466
hsa05014,Amyotrophic lateral sclerosis,Mutation-caused aberrant SOD1 to 26S proteasome-mediated protein degradation,N01144,Amyotrophic lateral sclerosis,nt06464
hsa05014,Amyotrophic lateral sclerosis,Mutation-caused aberrant SOD1 to 26S proteasome-mediated protein degradation,N01144,Pathways of neurodegeneration,nt06466
hsa05014,Amyotrophic lateral sclerosis,Mutation-inactivated VCP to 26S proteasome-mediated protein degradation,N01145,Amyotrophic lateral sclerosis,nt06464
hsa05014,Amyotrophic lateral sclerosis,Mutation-inactivated VCP to 26S proteasome-mediated protein degradation,N01145,Pathways of neurodegeneration,nt06466
hsa05014,Amyotrophic lateral sclerosis,Mutation-inactivated UBQLN2 to 26S proteasome-mediated protein degradation,N01146,Amyotrophic lateral sclerosis,nt06464
hsa05014,Amyotrophic lateral sclerosis,Mutation-inactivated UBQLN2 to 26S proteasome-mediated protein degradation,N01146,Pathways of neurodegeneration,nt06466
hsa05014,Amyotrophic lateral sclerosis,Mutation-caused aberrant SOD1 to PERK-ATF4 signaling pathway,N01149,Unfolded protein response,nt06534
hsa05014,Amyotrophic lateral sclerosis,Mutation-caused aberrant SOD1 to PERK-ATF4 signaling pathway,N01149,Amyotrophic lateral sclerosis,nt06464
hsa05014,Amyotrophic lateral sclerosis,Mutation-caused aberrant SOD1 to PERK-ATF4 signaling pathway,N01149,Pathways of neurodegeneration,nt06466
hsa05014,Amyotrophic lateral sclerosis,Mutation-caused aberrant SOD1 to IRE1a-XBP1 signaling pathway,N01148,Unfolded protein response,nt06534
hsa05014,Amyotrophic lateral sclerosis,Mutation-caused aberrant SOD1 to IRE1a-XBP1 signaling pathway,N01148,Amyotrophic lateral sclerosis,nt06464
hsa05014,Amyotrophic lateral sclerosis,Mutation-caused aberrant SOD1 to IRE1a-XBP1 signaling pathway,N01148,Pathways of neurodegeneration,nt06466
hsa05014,Amyotrophic lateral sclerosis,Mutation-inactivated VAPB to ATF6-mediated transcription,N01150,Unfolded protein response,nt06534
hsa05014,Amyotrophic lateral sclerosis,Mutation-inactivated VAPB to ATF6-mediated transcription,N01150,Amyotrophic lateral sclerosis,nt06464
hsa05014,Amyotrophic lateral sclerosis,Mutation-inactivated VAPB to ATF6-mediated transcription,N01150,Pathways of neurodegeneration,nt06466
hsa05014,Amyotrophic lateral sclerosis,Mutation-caused aberrant SOD1 to ATF6-mediated transcription,N01147,Unfolded protein response,nt06534
hsa05014,Amyotrophic lateral sclerosis,Mutation-caused aberrant SOD1 to ATF6-mediated transcription,N01147,Amyotrophic lateral sclerosis,nt06464
hsa05014,Amyotrophic lateral sclerosis,Mutation-caused aberrant SOD1 to ATF6-mediated transcription,N01147,Pathways of neurodegeneration,nt06466
hsa05014,Amyotrophic lateral sclerosis,Mutation-inactivated C9orf72 to C9orf72-mediated autophagy initiation,N01143,Amyotrophic lateral sclerosis,nt06464
hsa05014,Amyotrophic lateral sclerosis,Mutation-inactivated C9orf72 to C9orf72-mediated autophagy initiation,N01143,Pathways of neurodegeneration,nt06466
hsa05014,Amyotrophic lateral sclerosis,Mutation-inactivated OPTN to PINK-Parkin-mediated autophagosome formation,N01138,Amyotrophic lateral sclerosis,nt06464
hsa05014,Amyotrophic lateral sclerosis,Mutation-inactivated OPTN to PINK-Parkin-mediated autophagosome formation,N01138,Pathways of neurodegeneration,nt06466
hsa05014,Amyotrophic lateral sclerosis,Mutation-inactivated p62 to PINK-Parkin-mediated autophagosome formation,N01139,Amyotrophic lateral sclerosis,nt06464
hsa05014,Amyotrophic lateral sclerosis,Mutation-inactivated p62 to PINK-Parkin-mediated autophagosome formation,N01139,Pathways of neurodegeneration,nt06466
hsa05014,Amyotrophic lateral sclerosis,Mutation-inactivated TBK1 to TBK1-mediated autophagosome formation,N01141,Amyotrophic lateral sclerosis,nt06464
hsa05014,Amyotrophic lateral sclerosis,Mutation-inactivated TBK1 to TBK1-mediated autophagosome formation,N01141,Pathways of neurodegeneration,nt06466
hsa05014,Amyotrophic lateral sclerosis,Mutation-caused aberrant SOD1 to intrinsic apoptotic pathway,N01135,Amyotrophic lateral sclerosis,nt06464
hsa05014,Amyotrophic lateral sclerosis,Mutation-caused aberrant SOD1 to intrinsic apoptotic pathway,N01135,Pathways of neurodegeneration,nt06466
hsa05014,Amyotrophic lateral sclerosis,Mutation-inactivated ERBB4 to NRG-ERBB4-PI3K signaling pathway,N01164,Amyotrophic lateral sclerosis,nt06464
hsa05014,Amyotrophic lateral sclerosis,Mutation-caused aberrant TDP43 to electron transfer in Complex I,N01136,Amyotrophic lateral sclerosis,nt06464
hsa05014,Amyotrophic lateral sclerosis,Mutation-caused aberrant TDP43 to electron transfer in Complex I,N01136,Pathways of neurodegeneration,nt06466
hsa05014,Amyotrophic lateral sclerosis,Mutation-caused aberrant SOD1 to retrograde axonal transport,N01160,Amyotrophic lateral sclerosis,nt06464
hsa05014,Amyotrophic lateral sclerosis,Mutation-caused aberrant SOD1 to retrograde axonal transport,N01160,Pathways of neurodegeneration,nt06466
hsa05014,Amyotrophic lateral sclerosis,Mutation-caused aberrant DCTN1 to retrograde axonal transport,N01158,Amyotrophic lateral sclerosis,nt06464
hsa05014,Amyotrophic lateral sclerosis,Mutation-caused aberrant DCTN1 to retrograde axonal transport,N01158,Pathways of neurodegeneration,nt06466
hsa05014,Amyotrophic lateral sclerosis,Mutation-caused aberrant TUBA4A to retrograde axonal transport,N01159,Amyotrophic lateral sclerosis,nt06464
hsa05014,Amyotrophic lateral sclerosis,Mutation-caused aberrant TUBA4A to retrograde axonal transport,N01159,Pathways of neurodegeneration,nt06466
hsa05014,Amyotrophic lateral sclerosis,Mutation-caused aberrant PFN1 to actin polymerization,N01162,Amyotrophic lateral sclerosis,nt06464
hsa05014,Amyotrophic lateral sclerosis,Mutation-caused aberrant TDP43 to TDP-43-regulated splicing,N01155,Amyotrophic lateral sclerosis,nt06464
hsa05014,Amyotrophic lateral sclerosis,Mutation-caused aberrant FUS to FUS-regulated splicing,N01157,Amyotrophic lateral sclerosis,nt06464
hsa05014,Amyotrophic lateral sclerosis,Mutation-caused aberrant GLE1 to nuclear export of mRNA,N01153,Amyotrophic lateral sclerosis,nt06464
hsa05016,Huntington disease,Mutation-caused aberrant Htt to mGluR5-Ca2+ -apoptotic pathway,N00985,Huntington disease,nt06461
hsa05016,Huntington disease,Mutation-caused aberrant Htt to mGluR5-Ca2+ -apoptotic pathway,N00985,Pathways of neurodegeneration,nt06466
hsa05016,Huntington disease,Mutation-caused aberrant Htt to VGCC-Ca2+ -apoptotic pathway,N00986,Huntington disease,nt06461
hsa05016,Huntington disease,Mutation-caused aberrant Htt to VGCC-Ca2+ -apoptotic pathway,N00986,Pathways of neurodegeneration,nt06466
hsa05016,Huntington disease,Mutation-caused aberrant Htt to transport of calcium,N00987,Huntington disease,nt06461
hsa05016,Huntington disease,Mutation-caused aberrant Htt to transport of calcium,N00987,Pathways of neurodegeneration,nt06466
hsa05016,Huntington disease,Mutation-caused aberrant Htt to 26S proteasome-mediated protein degradation,N01061,Huntington disease,nt06461
hsa05016,Huntington disease,Mutation-caused aberrant Htt to 26S proteasome-mediated protein degradation,N01061,Pathways of neurodegeneration,nt06466
hsa05016,Huntington disease,Mutation-caused aberrant Htt to autophagy-vesicle nucleation,N00993,Huntington disease,nt06461
hsa05016,Huntington disease,Mutation-caused aberrant Htt to autophagy-vesicle nucleation,N00993,Pathways of neurodegeneration,nt06466
hsa05016,Huntington disease,Mutation-caused aberrant Htt to extrinsic apoptotic pathway,N00983,Huntington disease,nt06461
hsa05016,Huntington disease,Mutation-caused aberrant Htt to TNF-JNK signaling pathway,N00992,Huntington disease,nt06461
hsa05016,Huntington disease,Mutation-caused aberrant Htt to electron transfer in Complex II,N00989,Huntington disease,nt06461
hsa05016,Huntington disease,Mutation-caused aberrant Htt to electron transfer in Complex II,N00989,Pathways of neurodegeneration,nt06466
hsa05016,Huntington disease,Mutation-caused aberrant Htt to electron transfer in Complex III,N00991,Huntington disease,nt06461
hsa05016,Huntington disease,Mutation-caused aberrant Htt to electron transfer in Complex III,N00991,Pathways of neurodegeneration,nt06466
hsa05016,Huntington disease,Mutation-caused aberrant Htt to retrograde axonal transport,N00977,Huntington disease,nt06461
hsa05016,Huntington disease,Mutation-caused aberrant Htt to retrograde axonal transport,N00977,Pathways of neurodegeneration,nt06466
hsa05016,Huntington disease,Mutation-caused aberrant Htt to anterograde axonal transport,N00979,Huntington disease,nt06461
hsa05016,Huntington disease,Mutation-caused aberrant Htt to anterograde axonal transport,N00979,Pathways of neurodegeneration,nt06466
hsa05016,Huntington disease,Mutation-caused aberrant Htt to REST-mediated transcriptional repression,N00980,Huntington disease,nt06461
hsa05016,Huntington disease,Mutation-caused aberrant Htt to CREB-mediated transcription,N00981,Huntington disease,nt06461
hsa05016,Huntington disease,Mutation-caused aberrant Htt to p53-mediated transcription,N00982,Huntington disease,nt06461
hsa05017,Spinocerebellar ataxia,Mutation-caused aberrant SPTBN2 to mGluR1-TRPC3 signaling pathway,N00960,Spinocerebellar ataxia,nt06462
hsa05017,Spinocerebellar ataxia,Mutation-caused aberrant SPTBN2 to mGluR1-TRPC3 signaling pathway,N00960,Pathways of neurodegeneration,nt06466
hsa05017,Spinocerebellar ataxia,Mutation-activated GRM1 to mGluR1-TRPC3 signaling pathway,N00954,Spinocerebellar ataxia,nt06462
hsa05017,Spinocerebellar ataxia,Mutation-activated GRM1 to mGluR1-TRPC3 signaling pathway,N00954,Pathways of neurodegeneration,nt06466
hsa05017,Spinocerebellar ataxia,Mutation-activated ITPR1 to mGluR1-TRPC3 signaling pathway,N00958,Spinocerebellar ataxia,nt06462
hsa05017,Spinocerebellar ataxia,Mutation-activated ITPR1 to mGluR1-TRPC3 signaling pathway,N00958,Pathways of neurodegeneration,nt06466
hsa05017,Spinocerebellar ataxia,ITPR1-reduced expression to mGluR1-TRPC3 signaling pathway,N00959,Spinocerebellar ataxia,nt06462
hsa05017,Spinocerebellar ataxia,ITPR1-reduced expression to mGluR1-TRPC3 signaling pathway,N00959,Pathways of neurodegeneration,nt06466
hsa05017,Spinocerebellar ataxia,Mutation-inactivated PRKCG to mGluR1-TRPC3 signaling pathway,N00955,Spinocerebellar ataxia,nt06462
hsa05017,Spinocerebellar ataxia,Mutation-inactivated PRKCG to mGluR1-TRPC3 signaling pathway,N00955,Pathways of neurodegeneration,nt06466
hsa05017,Spinocerebellar ataxia,Mutation-activated PRKCG to mGluR1-TRPC3 signaling pathway,N00956,Spinocerebellar ataxia,nt06462
hsa05017,Spinocerebellar ataxia,Mutation-activated PRKCG to mGluR1-TRPC3 signaling pathway,N00956,Pathways of neurodegeneration,nt06466
hsa05017,Spinocerebellar ataxia,Mutation-activated TRPC3 to mGluR1-TRPC3 signaling pathway,N00961,Spinocerebellar ataxia,nt06462
hsa05017,Spinocerebellar ataxia,Mutation-activated TRPC3 to mGluR1-TRPC3 signaling pathway,N00961,Pathways of neurodegeneration,nt06466
hsa05017,Spinocerebellar ataxia,Mutation-caused abberant ATXN2/3 to mGluR5-Ca2+ -apoptotic pathway,N00957,Spinocerebellar ataxia,nt06462
hsa05017,Spinocerebellar ataxia,Mutation-caused abberant ATXN2/3 to mGluR5-Ca2+ -apoptotic pathway,N00957,Pathways of neurodegeneration,nt06466
hsa05017,Spinocerebellar ataxia,Mutation-activated CACNA1A to VGCC-Ca2+ -apoptotic pathway,N00968,Spinocerebellar ataxia,nt06462
hsa05017,Spinocerebellar ataxia,Mutation-activated CACNA1A to VGCC-Ca2+ -apoptotic pathway,N00968,Pathways of neurodegeneration,nt06466
hsa05017,Spinocerebellar ataxia,Mutation-inactivated CACNA1A to VGCC-Ca2- -apoptotic pathway,N00969,Spinocerebellar ataxia,nt06462
hsa05017,Spinocerebellar ataxia,Mutation-inactivated CACNA1A to VGCC-Ca2- -apoptotic pathway,N00969,Pathways of neurodegeneration,nt06466
hsa05017,Spinocerebellar ataxia,Mutation-caused aberrant PDYN to transport of calcium,N00971,Spinocerebellar ataxia,nt06462
hsa05017,Spinocerebellar ataxia,Mutation-caused aberrant PDYN to transport of calcium,N00971,Pathways of neurodegeneration,nt06466
hsa05017,Spinocerebellar ataxia,Mutation-inactivated KCNC3 to transport of potassium,N00973,Spinocerebellar ataxia,nt06462
hsa05017,Spinocerebellar ataxia,Mutation-inactivated KCND3 to transport of potassium,N00975,Spinocerebellar ataxia,nt06462
hsa05017,Spinocerebellar ataxia,Mutation-inactivated ATXN3 to autophagy-vesicle nucleation,N00962,Spinocerebellar ataxia,nt06462
hsa05017,Spinocerebellar ataxia,Mutation-inactivated ATXN3 to autophagy-vesicle nucleation,N00962,Pathways of neurodegeneration,nt06466
hsa05017,Spinocerebellar ataxia,DAB1-overexpression to RELN-VLDLR-PI3K signaling pathway,N00964,Spinocerebellar ataxia,nt06462
hsa05017,Spinocerebellar ataxia,Mutation-caused aberrant ATXN1 to RORA-mediated transcription,N00966,Spinocerebellar ataxia,nt06462
hsa05020,Prion disease,Scrapie conformation PrPSc to mGluR5-Ca2+ -apoptotic pathway,N01199,Prion disease,nt06465
hsa05020,Prion disease,Scrapie conformation PrPSc to mGluR5-Ca2+ -apoptotic pathway,N01199,Pathways of neurodegeneration,nt06466
hsa05020,Prion disease,Scrapie conformation PrPSc to VGCC-Ca2+ -apoptotic pathway,N01201,Prion disease,nt06465
hsa05020,Prion disease,Scrapie conformation PrPSc to VGCC-Ca2+ -apoptotic pathway,N01201,Pathways of neurodegeneration,nt06466
hsa05020,Prion disease,Scrapie conformation PrPSc to transport of calcium,N01200,Prion disease,nt06465
hsa05020,Prion disease,Scrapie conformation PrPSc to transport of calcium,N01200,Pathways of neurodegeneration,nt06466
hsa05020,Prion disease,Scrapie conformation PrPSc to 26S proteasome-mediated protein degradation,N01197,Prion disease,nt06465
hsa05020,Prion disease,Scrapie conformation PrPSc to 26S proteasome-mediated protein degradation,N01197,Pathways of neurodegeneration,nt06466
hsa05020,Prion disease,Scrapie conformation PrPSc to PERK-ATF4 signaling pathway,N01198,Unfolded protein response,nt06534
hsa05020,Prion disease,Scrapie conformation PrPSc to PERK-ATF4 signaling pathway,N01198,Prion disease,nt06465
hsa05020,Prion disease,Scrapie conformation PrPSc to PERK-ATF4 signaling pathway,N01198,Pathways of neurodegeneration,nt06466
hsa05020,Prion disease,Scrapie conformation PrPSc to PRNP-PI3K-NOX2 signaling pathway,N01205,Prion disease,nt06465
hsa05020,Prion disease,Oligomeric conformation PrPc to anterograde axonal transport,N01202,Prion disease,nt06465
hsa05020,Prion disease,Oligomeric conformation PrPc to anterograde axonal transport,N01202,Pathways of neurodegeneration,nt06466
hsa05020,Prion disease,Scrapie conformation PrPSc to Notch singling pathway,N01203,Prion disease,nt06465
hsa04730,Long-term depression,mGluR1-TRPC3 signaling pathway,N00953,Calcium signaling,nt06528
hsa04730,Long-term depression,mGluR1-TRPC3 signaling pathway,N00953,Parkinson disease,nt06463
hsa04730,Long-term depression,mGluR1-TRPC3 signaling pathway,N00953,Spinocerebellar ataxia,nt06462
hsa04730,Long-term depression,mGluR1-TRPC3 signaling pathway,N00953,Pathways of neurodegeneration,nt06466
hsa04720,Long-term potentiation,mGluR5-Ca2+ -apoptotic pathway,N00984,Calcium signaling,nt06528
hsa04720,Long-term potentiation,mGluR5-Ca2+ -apoptotic pathway,N00984,Alzheimer disease,nt06460
hsa04720,Long-term potentiation,mGluR5-Ca2+ -apoptotic pathway,N00984,Amyotrophic lateral sclerosis,nt06464
hsa04720,Long-term potentiation,mGluR5-Ca2+ -apoptotic pathway,N00984,Huntington disease,nt06461
hsa04720,Long-term potentiation,mGluR5-Ca2+ -apoptotic pathway,N00984,Spinocerebellar ataxia,nt06462
hsa04720,Long-term potentiation,mGluR5-Ca2+ -apoptotic pathway,N00984,Prion disease,nt06465
hsa04720,Long-term potentiation,mGluR5-Ca2+ -apoptotic pathway,N00984,Pathways of neurodegeneration,nt06466
hsa04020,Calcium signaling pathway,mAChR-Ca2+ -apoptotic pathway,N01000,Calcium signaling,nt06528
hsa04020,Calcium signaling pathway,mAChR-Ca2+ -apoptotic pathway,N01000,Alzheimer disease,nt06460
hsa04020,Calcium signaling pathway,mAChR-Ca2+ -apoptotic pathway,N01000,Pathways of neurodegeneration,nt06466
hsa04724,Glutamatergic synapse,VGCC-Ca2+ -apoptotic pathway,N00967,Alzheimer disease,nt06460
hsa04724,Glutamatergic synapse,VGCC-Ca2+ -apoptotic pathway,N00967,Parkinson disease,nt06463
hsa04724,Glutamatergic synapse,VGCC-Ca2+ -apoptotic pathway,N00967,Huntington disease,nt06461
hsa04724,Glutamatergic synapse,VGCC-Ca2+ -apoptotic pathway,N00967,Spinocerebellar ataxia,nt06462
hsa04724,Glutamatergic synapse,VGCC-Ca2+ -apoptotic pathway,N00967,Prion disease,nt06465
hsa04724,Glutamatergic synapse,VGCC-Ca2+ -apoptotic pathway,N00967,Pathways of neurodegeneration,nt06466
hsa04724,Glutamatergic synapse,Transport of calcium,N00970,Alzheimer disease,nt06460
hsa04724,Glutamatergic synapse,Transport of calcium,N00970,Huntington disease,nt06461
hsa04724,Glutamatergic synapse,Transport of calcium,N00970,Spinocerebellar ataxia,nt06462
hsa04724,Glutamatergic synapse,Transport of calcium,N00970,Prion disease,nt06465
hsa04724,Glutamatergic synapse,Transport of calcium,N00970,Pathways of neurodegeneration,nt06466
hsa04120,Ubiquitin mediated proteolysis,Parkin-mediated ubiquitination,N01019,Parkinson disease,nt06463
hsa04120,Ubiquitin mediated proteolysis,Parkin-mediated ubiquitination,N01019,Pathways of neurodegeneration,nt06466
hsa04120,Ubiquitin mediated proteolysis,Parkin-mediated ubiquitination,N01021,Parkinson disease,nt06463
hsa04120,Ubiquitin mediated proteolysis,Parkin-mediated ubiquitination,N01021,Pathways of neurodegeneration,nt06466
hsa04120,Ubiquitin mediated proteolysis,Parkin-mediated ubiquitination,N01023,Parkinson disease,nt06463
hsa04120,Ubiquitin mediated proteolysis,Parkin-mediated ubiquitination,N01023,Pathways of neurodegeneration,nt06466
hsa04120,Ubiquitin mediated proteolysis,Parkin-mediated ubiquitination,N01025,Parkinson disease,nt06463
hsa04120,Ubiquitin mediated proteolysis,Parkin-mediated ubiquitination,N01025,Pathways of neurodegeneration,nt06466
hsa03050,Proteasome,26S proteasome-mediated protein degradation,N01029,Alzheimer disease,nt06460
hsa03050,Proteasome,26S proteasome-mediated protein degradation,N01029,Parkinson disease,nt06463
hsa03050,Proteasome,26S proteasome-mediated protein degradation,N01029,Amyotrophic lateral sclerosis,nt06464
hsa03050,Proteasome,26S proteasome-mediated protein degradation,N01029,Huntington disease,nt06461
hsa03050,Proteasome,26S proteasome-mediated protein degradation,N01029,Prion disease,nt06465
hsa03050,Proteasome,26S proteasome-mediated protein degradation,N01029,Pathways of neurodegeneration,nt06466
hsa05012,Parkinson disease,UCHL1-mediated hydrolysis,N01027,Parkinson disease,nt06463
hsa05012,Parkinson disease,UCHL1-mediated hydrolysis,N01027,Pathways of neurodegeneration,nt06466
hsa04141,Protein processing in endoplasmic reticulum,PERK-ATF4 signaling pathway,N01009,Unfolded protein response,nt06534
hsa04141,Protein processing in endoplasmic reticulum,PERK-ATF4 signaling pathway,N01009,Alzheimer disease,nt06460
hsa04141,Protein processing in endoplasmic reticulum,PERK-ATF4 signaling pathway,N01009,Parkinson disease,nt06463
hsa04141,Protein processing in endoplasmic reticulum,PERK-ATF4 signaling pathway,N01009,Amyotrophic lateral sclerosis,nt06464
hsa04141,Protein processing in endoplasmic reticulum,PERK-ATF4 signaling pathway,N01009,Prion disease,nt06465
hsa04141,Protein processing in endoplasmic reticulum,PERK-ATF4 signaling pathway,N01009,Pathways of neurodegeneration,nt06466
hsa04141,Protein processing in endoplasmic reticulum,IRE1a-XBP1 signaling pathway,N01011,Unfolded protein response,nt06534
hsa04141,Protein processing in endoplasmic reticulum,IRE1a-XBP1 signaling pathway,N01011,Alzheimer disease,nt06460
hsa04141,Protein processing in endoplasmic reticulum,IRE1a-XBP1 signaling pathway,N01011,Parkinson disease,nt06463
hsa04141,Protein processing in endoplasmic reticulum,IRE1a-XBP1 signaling pathway,N01011,Amyotrophic lateral sclerosis,nt06464
hsa04141,Protein processing in endoplasmic reticulum,IRE1a-XBP1 signaling pathway,N01011,Pathways of neurodegeneration,nt06466
hsa04141,Protein processing in endoplasmic reticulum,IRE1a-JNK signaling pathway,N01013,Unfolded protein response,nt06534
hsa04141,Protein processing in endoplasmic reticulum,IRE1a-JNK signaling pathway,N01013,Alzheimer disease,nt06460
hsa04141,Protein processing in endoplasmic reticulum,IRE1a-JNK signaling pathway,N01013,Pathways of neurodegeneration,nt06466
hsa04141,Protein processing in endoplasmic reticulum,ATF6-mediated transcription,N01015,Unfolded protein response,nt06534
hsa04141,Protein processing in endoplasmic reticulum,ATF6-mediated transcription,N01015,Alzheimer disease,nt06460
hsa04141,Protein processing in endoplasmic reticulum,ATF6-mediated transcription,N01015,Parkinson disease,nt06463
hsa04141,Protein processing in endoplasmic reticulum,ATF6-mediated transcription,N01015,Amyotrophic lateral sclerosis,nt06464
hsa04141,Protein processing in endoplasmic reticulum,ATF6-mediated transcription,N01015,Pathways of neurodegeneration,nt06466
hsa04140,Autophagy - animal,C9orf72-mediated autophagy initiation,N01142,Autophagy,nt06532
hsa04140,Autophagy - animal,C9orf72-mediated autophagy initiation,N01142,Amyotrophic lateral sclerosis,nt06464
hsa04140,Autophagy - animal,C9orf72-mediated autophagy initiation,N01142,Pathways of neurodegeneration,nt06466
hsa04140,Autophagy - animal,"Autophagy-vesicle nucleation/elongation/maturation, mTORC1-PI3KC3-C1",N00155,Autophagy,nt06532
hsa04140,Autophagy - animal,"Autophagy-vesicle nucleation/elongation/maturation, mTORC1-PI3KC3-C1",N00155,Huntington disease,nt06461
hsa04140,Autophagy - animal,"Autophagy-vesicle nucleation/elongation/maturation, mTORC1-PI3KC3-C1",N00155,Spinocerebellar ataxia,nt06462
hsa04140,Autophagy - animal,"Autophagy-vesicle nucleation/elongation/maturation, mTORC1-PI3KC3-C1",N00155,Pathways of neurodegeneration,nt06466
hsa04140,Autophagy - animal,"Autophagy-vesicle nucleation/elongation/maturation, mTORC1-PI3KC3-C1",N00155,Kaposi sarcoma-associated herpesvirus (KSHV),nt06164
hsa04137,Mitophagy - animal,PINK1-Parkin-mediated MFN2 degradation,N01052,Parkinson disease,nt06463
hsa04137,Mitophagy - animal,PINK1-Parkin-mediated MFN2 degradation,N01052,Pathways of neurodegeneration,nt06466
hsa04137,Mitophagy - animal,PINK-Parkin-mediated autophagosome formation,N01137,Amyotrophic lateral sclerosis,nt06464
hsa04137,Mitophagy - animal,PINK-Parkin-mediated autophagosome formation,N01137,Pathways of neurodegeneration,nt06466
hsa04137,Mitophagy - animal,TBK1-mediated autophagosome formation,N01140,Mitophagy,nt06536
hsa04137,Mitophagy - animal,TBK1-mediated autophagosome formation,N01140,Amyotrophic lateral sclerosis,nt06464
hsa04137,Mitophagy - animal,TBK1-mediated autophagosome formation,N01140,Pathways of neurodegeneration,nt06466
hsa04210,Apoptosis,Crosstalk between extrinsic and intrinsic apoptotic pathways,N00146,Apoptosis,nt06524
hsa04210,Apoptosis,Crosstalk between extrinsic and intrinsic apoptotic pathways,N00146,Hepatocellular carcinoma,nt06263
hsa04210,Apoptosis,Crosstalk between extrinsic and intrinsic apoptotic pathways,N00146,Apoptosis (cancer),nt06231
hsa04210,Apoptosis,Crosstalk between extrinsic and intrinsic apoptotic pathways,N00146,Alzheimer disease,nt06460
hsa04210,Apoptosis,Crosstalk between extrinsic and intrinsic apoptotic pathways,N00146,Pathways of neurodegeneration,nt06466
hsa04210,Apoptosis,Crosstalk between extrinsic and intrinsic apoptotic pathways,N00146,Human immunodeficiency virus 1 (HIV-1),nt06161
hsa04210,Apoptosis,Crosstalk between extrinsic and intrinsic apoptotic pathways,N00146,Hepatitis B virus (HBV),nt06162
hsa04210,Apoptosis,Crosstalk between extrinsic and intrinsic apoptotic pathways,N00146,Hepatitis C virus (HCV),nt06163
hsa04210,Apoptosis,Crosstalk between extrinsic and intrinsic apoptotic pathways,N00146,Herpes simplex virus 1 (HSV-1),nt06168
hsa04210,Apoptosis,Crosstalk between extrinsic and intrinsic apoptotic pathways,N00146,Human cytomegalovirus (HCMV),nt06167
hsa04210,Apoptosis,Crosstalk between extrinsic and intrinsic apoptotic pathways,N00146,Kaposi sarcoma-associated herpesvirus (KSHV),nt06164
hsa04210,Apoptosis,Crosstalk between extrinsic and intrinsic apoptotic pathways,N00146,Epstein-Barr virus (EBV),nt06165
hsa04210,Apoptosis,Intrinsic apoptotic pathway,N00098,Apoptosis,nt06524
hsa04210,Apoptosis,Intrinsic apoptotic pathway,N00098,Colorectal cancer,nt06260
hsa04210,Apoptosis,Intrinsic apoptotic pathway,N00098,Small cell lung cancer,nt06267
hsa04210,Apoptosis,Intrinsic apoptotic pathway,N00098,Apoptosis (cancer),nt06231
hsa04210,Apoptosis,Intrinsic apoptotic pathway,N00098,Parkinson disease,nt06463
hsa04210,Apoptosis,Intrinsic apoptotic pathway,N00098,Amyotrophic lateral sclerosis,nt06464
hsa04210,Apoptosis,Intrinsic apoptotic pathway,N00098,Pathways of neurodegeneration,nt06466
hsa04210,Apoptosis,Intrinsic apoptotic pathway,N00098,Human immunodeficiency virus 1 (HIV-1),nt06161
hsa04210,Apoptosis,Intrinsic apoptotic pathway,N00098,Influenza A virus (IAV),nt06170
hsa04210,Apoptosis,Intrinsic apoptotic pathway,N00098,Herpes simplex virus 1 (HSV-1),nt06168
hsa04210,Apoptosis,Intrinsic apoptotic pathway,N00098,Epstein-Barr virus (EBV),nt06165
hsa04210,Apoptosis,Intrinsic apoptotic pathway,N00098,Human papillomavirus (HPV),nt06166
hsa05010,Alzheimer disease,AGE-RAGE signaling pathway,N00994,Alzheimer disease,nt06460
hsa05010,Alzheimer disease,AGE-RAGE signaling pathway,N00994,Pathways of neurodegeneration,nt06466
hsa00190,Oxidative phosphorylation,Electron transfer in Complex I,N00995,Alzheimer disease,nt06460
hsa00190,Oxidative phosphorylation,Electron transfer in Complex I,N00995,Parkinson disease,nt06463
hsa00190,Oxidative phosphorylation,Electron transfer in Complex I,N00995,Amyotrophic lateral sclerosis,nt06464
hsa00190,Oxidative phosphorylation,Electron transfer in Complex I,N00995,Pathways of neurodegeneration,nt06466
hsa00190,Oxidative phosphorylation,Electron transfer in Complex II,N00988,Mitochondrial ROS formation (cancer),nt06252
hsa00190,Oxidative phosphorylation,Electron transfer in Complex II,N00988,Alzheimer disease,nt06460
hsa00190,Oxidative phosphorylation,Electron transfer in Complex II,N00988,Parkinson disease,nt06463
hsa00190,Oxidative phosphorylation,Electron transfer in Complex II,N00988,Huntington disease,nt06461
hsa00190,Oxidative phosphorylation,Electron transfer in Complex II,N00988,Pathways of neurodegeneration,nt06466
hsa00190,Oxidative phosphorylation,Electron transfer in Complex III,N00990,Mitochondrial ROS formation (cancer),nt06252
hsa00190,Oxidative phosphorylation,Electron transfer in Complex III,N00990,Parkinson disease,nt06463
hsa00190,Oxidative phosphorylation,Electron transfer in Complex III,N00990,Huntington disease,nt06461
hsa00190,Oxidative phosphorylation,Electron transfer in Complex III,N00990,Pathways of neurodegeneration,nt06466
hsa00190,Oxidative phosphorylation,Electron transfer in Complex IV,N00998,Mitochondrial ROS formation (cancer),nt06252
hsa00190,Oxidative phosphorylation,Electron transfer in Complex IV,N00998,Alzheimer disease,nt06460
hsa00190,Oxidative phosphorylation,Electron transfer in Complex IV,N00998,Pathways of neurodegeneration,nt06466
hsa05016,Huntington disease,Retrograde axonal transport,N00976,Parkinson disease,nt06463
hsa05016,Huntington disease,Retrograde axonal transport,N00976,Amyotrophic lateral sclerosis,nt06464
hsa05016,Huntington disease,Retrograde axonal transport,N00976,Huntington disease,nt06461
hsa05016,Huntington disease,Retrograde axonal transport,N00976,Pathways of neurodegeneration,nt06466
hsa05016,Huntington disease,Anterograde axonal transport,N00978,Alzheimer disease,nt06460
hsa05010,Alzheimer disease,Anterograde axonal transport,N00978,Huntington disease,nt06461
hsa05010,Alzheimer disease,Anterograde axonal transport,N00978,Prion disease,nt06465
hsa05010,Alzheimer disease,Anterograde axonal transport,N00978,Pathways of neurodegeneration,nt06466
